Early development of skin rash following lapatinib and trastuzumab therapy is associated with improved survival.
Lapatinib as first-line treatment for muscle-invasive urothelial
Molecules, Free Full-Text
Lapatinib: Package Insert
Wendy A. Woodward, M.D., Ph.D., Radiation Oncologist
Page 1537 – Cancer Therapy Advisor
First-line lapatinib trials in metastatic breast cancer
Lapatinib: Package Insert
PDF] Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO
Pyrotinib-based therapeutic approaches for HER2-positive breast